Fall 2024 | Volume 10 Issue 3

Dear SPARTAN Community,

I am honored to introduce myself as the new Chair of the Spondyloarthritis Research and Treatment Network (SPARTAN). As reflected in our mission statement, our pillars continue to be advancement of research and education. Additionally, a new and evolving focus is support of junior SPARTAN members through targeted research grants and mentorship.

Research

Our research program is a mixture of major SPARTAN-led initiatives and a grants program supporting junior investigators. The CLASSIC study, an international effort to validate the ASAS 2009 classification criteria for axial SpA, completed enrolment in 2022; data from this study will be presented at the ACR 2024 Convergence, and much more data will be forthcoming. SPARTAN is also planning a biomarker study taking advantage of the infrastructure developed for CLASSIC. We also have several programs supporting junior investigators. These are the mentored fellowship award (a one year $10,000 award), the Early Career Investigator award ($25,000 / year x two years), and a new $100,000 Spondyloarthritis Research Fellowship generously supported by UCB that is targeted to junior members who need to reach out to different institutions to find spondyloarthritis mentorship. Additional grants targeting fellows and junior faculty are in the planning stages!

Education

SPARTAN’s education mission extends to all levels of learners. The SpA review course adjacent to the Annual Meeting, while developed for fellows, is a terrific review for learners at all levels. The SPARTAN GRAPPA ASAS symposium will once again be held at the conclusion of ACR Convergence on Tuesday, November 19 from 12:30 – 2:30 p.m. at the Marriott Marquis. We are also developing educational symposia around the world to enhance our international reputation and as well benefit patients and providers who may not otherwise have access to the latest information. Additional educational efforts are targeted towards our referring provider base. This includes the Early Identification and Diagnosis of Axial Spondyloarthritis (EIDA) program sponsored by Pfizer, through which we have given 54 talks to over 3000 audience members about the nature of axial SpA and as well upcoming publication of SPARTAN referral recommendations, a project led by Drs. Maureen Dubreuil and Abhijeet Danve, that aims to provide guidance on which adults with chronic back pain should be referred to rheumatology.

Mentorship

A new initiative introduced last summer on a trial basis is the SPARTAN Training and Mentorship Program (STAMP). A unique and significant feature of STAMP is the manual matching of prospective mentors and mentees based on shared interests, such as clinical trials, outcomes research, and basic science.

Networking

Every year, the feedback from the annual meeting includes requests for additional networking opportunities. We have taken a big step in that direction through development of the second annual SPARTAN Member Forum at ACR Convergence 2024, to be held Saturday November 16 at the Mariott Marquis from 5:30 – 7:30 PM. As part of the forum, we are introducing the Collaborator Connection, geared towards SPARTAN researchers who wish to introduce themselves to the community to meet potential collaborators.

Of course, our most important networking opportunity each year is the SPARTAN Annual Meeting. We are pleased to announce that the 2025 Annual Meeting will be held in Toronto, Canada at the Toronto Hilton Hotel May 9-10 , with the Spondyloarthritis Review Course as always being held the preceding day on Thursday, May 8).

Sponsors

Finally, none of this would be possible without the generous support of our sponsors. On behalf of SPARTAN, I wish to extend our heartfelt gratitude to our diamond sponsors AbbVie, Novartis, and UCB; our gold sponsor J&J Innovative Medicine; and our silver sponsors Lilly and Pfizer. Furthermore, several of our educational and research programs receive supplementary funding, and we extend our gratitude to our sponsors for this additional support.

In conclusion, I wish to thank all of you for your continued support and dedication to advancing the field of spondyloarthritis. I look forward to seeing you at the SPARTAN Member Forum in Washington DC and invite you to work with us to enhance our mission!


Regards, Matt

Matthew Stoll, MD, PhD, MSCS

Professor, Pediatric Rheumatology

University of Alabama at Birmingham


 
 
Register for Member Forum dinner

Dear SPARTAN community,


As the Chair of the Communication Committee at SPARTAN, I want to take a moment to express our commitment to keeping you informed and engaged with the latest developments in our organization and the field of axSpA.

In an era where information is more vital than ever, we understand the importance of clear, timely, and accessible communication. To that end, we are dedicated to providing you with up-to-date information through multiple channels including quarterly newsletters, social media and email updates about funding and networking opportunities.

Thank you for your support and engagement. Your feedback is invaluable, and we encourage you to reach out with any suggestions. Together, we can advance our mission and make a meaningful impact on the field of spondyloarthritis.


Warm regards,


Abhijeet Danve, MD,MHS

Associate Professor of Medicine

Director, Yale Spondyloarthritis Program

Yale School of Medicine

SPARTAN PROJECT UPDATES


CLASSIC

The SPARTAN and ASAS CLASSIC steering committees are working collaboratively towards a consensus on a final sent of classification criteria. Each committee has now identified a couple of high priority candidate models for the classification criteria that have high face validity and also perform well in the testing dataset. Further analysis of their performance has now been conducted in the validation dataset and the results will be discussed within the next month. Selection of the final model(s) for discussion and voting by ASAS and SPARTAN members will be based on considerations related to face validity, feasibility, and attainment of prespecified sensitivity/specificity targets of 75%/90%. ...Walter Maksymowych and team


Referral Recommendation Project

Members of the SPARTAN Referral Recommendations project team worked tirelessly for last 2 years to develop evidence-based recommendations using rigorous scientific methods. The final SPARTAN-endorsed referral recommendations for referral of adults with chronic back pain at increased risk of axial spondyloarthritis to rheumatologists, were presented at SPARTAN 2024. Manuscripts from the project are being submitted for publication. The next steps would be effective dissemination and implementation of the recommendations as well as validation studies. ...Abhijeet Danve and team


BASIS

We are thrilled to announce that the Biomarkers in Axial Spondyloarthritis Investigative Study (BASIS) is gaining momentum! The BASIS project team leaders are busy working through contracting issues and the project is now one step closer to initiating this groundbreaking study. BASIS has ambitious goals that promise to reshape the diagnosis and understanding of Axial Spondyloarthritis (AS). Central to this effort is the discovery of biomarkers that could revolutionize disease detection, leading to earlier and more accurate diagnoses. In addition to this pivotal work, BASIS will establish a state-of-the-art biobank and image acquisitions, providing an invaluable resource for future research efforts. This biobank will be instrumental for the SPARTAN group and other researchers dedicated to advancing knowledge in Axial Spondyloarthritis. As the project advances, we invite clinical and research sites to declare your interest in this exciting endeavor. This is a unique opportunity to be part of a collaborative effort that will drive innovation in biomarker discovery and MRI standardization. ...Sibel Aydin and team

SpA at ACR Convergence

 

Spondyloarthritis Sessions

Here's the full calendar of SpA events at ACR

 

SpA Abstracts

View all the SpA Abstract Sessions


Listing of oral and poster abstracts


 
 

SPARTAN Member Forum

Register for Member Forum Dinner

Congratulations SPARTAN Members Recognized at the 2024 Annual Meeting

Early Career Investigator Award ($25,000 per year for two years)

Mohamad Bittar (Oregon Health & Science University) “Characterizing Nociplastic Pain in Axial Spondyloarthritis: a prospective longitudinal study”


Rachael Stovall (University of Washington)

“Sex differences in real world treatment patterns and drug adherence in axial spondyloarthritis: a comprehensive assessment from the RISE registry and Medicare claims”


Mentored Fellowship Award ($10,000 award )

Kristen Mengwasser and Lianne Gensler, MD (University of California San Francisco)

“Mapping the peptide-binding repertoires of SpA-associated versus SpA-neutral HLA-B*27 alleles, using a high-throughput genetic screening platform”


Oral Abstracts ($1000 travel award) Sarah Danielson (University of Colorado) "Transcriptional and Epigenetic Analysis of Gut-Joint Trafficked T cells Suggest Regulatory Functions during Homeostasis"


Jose A. Meade-Aguilar (Boston University)

Nonsteroidal Anti-Inflammatory Drug Use and Incident Hypertension among Patients with Axial Spondyloarthritis: Insights from the DESIR Cohort


Patricia Remalante-Rayco, MD (Schroeder Arthritis Institute, University Health Network)

The Added Utility of Hybrid Positron Emission Tomography-Magnetic Resonance (PET-MR) Imaging over Magnetic Resonance Imaging (MRI) Alone in Diagnosing Axial Spondyloarthritis

 
 

Welcome New SPARTAN Members

to spartan
 


Full: Denis Poddubnyy


Associate: Brooke Beckett, Priyanka Chandratre, Priyanka Iyer, Megan Lane, Asha Thomas, Richard Zamore (from trainee)


Trainee: Sarah Danielson, Christine Loftis, Kristen Mengwasser, Asim Mohamed, Yawen Ren, Amy Trang

 
 
Canada travel information
 
 

Thank You to our Supporters

LinkedIn  Instagram  X